Cancer clinical trials in the region Île-de-France

609 currently recruiting clinical trials
Region Île-de-France

Phase 3 Sarcoma and GIST #NCT06127407 #2023-508507-20-00
Bone sarcoma Chondrosarcoma Locally Advanced Metastatic None 1 Systemic Treatment-Naive Chemotherapy Targeted therapy
8 recruiting sites
Phase 3 Lung cancer Colon cancer Rectal cancer Pancreas cancer Sarcoma and GIST #NCT06332274 #2023-503316-33-00
NSCLC (Non-Small Cell Lung Cancer) Soft tissue sarcoma Localized Locally Advanced None Surgery Chemotherapy Surgery Chemotherapy
EGFR Immunotherapy Immunotherapy
4 recruiting sites
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Acute leukemia #NCT03655145
Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) None Chemotherapy
1 recruiting site
Assistance Publique - Hôpitaux de Paris
Phase 3 Head and neck cancer #NCT07276399 #2025-521917-24-00
Oral cavity Oropharynx Hypopharynx Larynx Squamous cell carcinoma Locally Advanced Metastatic None Systemic Treatment-Naive
9 recruiting sites
Janssen
Phase 3 Head and neck cancer #NCT04747054
Oral cavity Oropharynx Hypopharynx Larynx Other Squamous cell carcinoma Metastatic None Systemic Treatment-Naive CPS Positive (1 <= X < 20) CPS Positive (X >= 20)
20 recruiting sites
UNICANCER
Phase 3 Head and neck cancer #NCT06798922
Oral cavity Oropharynx Localized None Surgery
2 recruiting sites
Centre François Baclesse
Phase 3 Stomach and esophageal cancer #NCT06644781 #2023-509630-19-00
Esophagus Squamous cell carcinoma Locally Advanced Metastatic 1 Immunotherapy Chemotherapy
Systemic Treatment-Naive
10 recruiting sites
Daiichi Sankyo
Phase 3 Prostate cancer #NCT06925737 #2024-517423-40-00
Adenocarcinoma Metastatic Castration-resistant 1 2 Targeted therapy Hormone therapy
Systemic Treatment-Naive Chemotherapy
8 recruiting sites
Merck Sharp & Dohme LLC
Phase 3 Lung cancer #NCT06119581 #2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12C None Systemic Treatment-Naive
BRAF EGFR HER2 MET NTRK-1/2/3 RET ROS-1 Immunotherapy Chemotherapy Targeted therapy
18 recruiting sites
Eli Lilly et compagnie